Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
725
-75
-9% -$23.6K 0.01% 373
2026
Q1
$271K Buy
800
+3
+0.4% +$1.08K 0.01% 309
2025
Q4
$280K Sell
797
-65
-8% -$23.7K 0.01% 299
2025
Q3
$319K Sell
862
-366
-30% -$141K 0.01% 289
2025
Q2
$486K Buy
1,228
+322
+36% +$120K 0.02% 226
2025
Q1
$337K Sell
906
-35
-4% -$13.3K 0.01% 262
2024
Q4
$339K Buy
941
+205
+28% +$76K 0.01% 233
2024
Q3
$266K Buy
736
+18
+3% +$6.21K 0.01% 267
2024
Q2
$244K Buy
718
+28
+4% +$9.48K 0.01% 264
2024
Q1
$247K Buy
+690
New +$232K 0.01% 260

Other funds holding SYK

Plancorp LLC's SYK Position: Q2 2026 in Review

Plancorp LLC reduced its Stryker (SYK) stake by 9.4% in Q2 2026, selling an estimated $23.6K and leaving 725 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #373.

Plancorp LLC first reported a position in SYK in Q1 2024 and has held it in 10 quarters since. The position peaked at $486K in Q2 2025. 636 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Plancorp LLC held 725 shares of Stryker worth $240K as of Q2 2026.
  • Plancorp LLC sold 75 Stryker shares in Q2 2026, an estimated $23.6K.
  • Stryker made up 0.01% of Plancorp LLC's portfolio in Q2 2026, its #373 holding.
  • Plancorp LLC first reported a position in Stryker in Q1 2024 and has held it in 10 quarters since.
  • Plancorp LLC's Stryker position peaked at $486K in Q2 2025.
  • 636 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.